Medtronic taps new VP of global clinical research and analytics: 4 highlights

Written by Mackenzie Garrity | April 09, 2018 | Print  |

Medtronic named Laura Mauri, MD, its new vice president of global clinical research and analytics, according to the Star Tribune.

Here are four highlights.

1. Dr. Mauri will begin the transition into her new role later in June. She will officially assume the role Sept. 1 and report to Medtronic's Chief Medical and Scientific Officer Rick Kuntz, MD.

2. She is a leading cardiologist who gained recognition for her role in the DAPT trial, and international clinical study including more than 25,000 stent patients to address questions on antiplatelet drug consumption length.

3. Dr. Mauri will continue serving as a professor at Boston-based Harvard Medical School. However, she will step down from her role at Boston-based Brigham and Women's Hospital.

4. As vice president of global clinical research and analytics, Dr. Mauri will push Medtronic's efforts toward value-based care contracts.

More articles on devices and implants:
15 orthopedic, spine device companies that may be affected by Trump's 25% tariff proposal
Globus Medical launches 2 expandable lateral spacer systems: 4 insights
Medicrea registers 8% drop in 2017 sales; Q1 2018 sales jump 25% from Q1 2017 — 9 observations

© Copyright ASC COMMUNICATIONS 2020. Interested in LINKING to or REPRINTING this content? View our policies here.

Featured Webinars

Featured Whitepapers